BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 27978952)

  • 1. Prosthetic Heart Valve Thrombosis.
    Dangas GD; Weitz JI; Giustino G; Makkar R; Mehran R
    J Am Coll Cardiol; 2016 Dec; 68(24):2670-2689. PubMed ID: 27978952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation After Heart Valve Replacement or Transcatheter Valve Implantation.
    Carnicelli AP; O'Gara PT; Giugliano RP
    Am J Cardiol; 2016 Nov; 118(9):1419-1426. PubMed ID: 27666180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valvular Heart Disease in Adults: Management of Prosthetic Heart Valves.
    Trujillo JF; Hollenberg SM
    FP Essent; 2017 Jun; 457():23-29. PubMed ID: 28671806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves.
    Chesebro JH; Adams PC; Fuster V
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):41B-56B. PubMed ID: 3537070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to define valvular atrial fibrillation?
    Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A
    Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of artificial heart valve replacement in infants and children.
    Tong E
    J Cardiovasc Nurs; 1992 Apr; 6(3):30-43. PubMed ID: 1556584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
    Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
    J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
    Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioprosthetic heart valves: modes of failure.
    Siddiqui RF; Abraham JR; Butany J
    Histopathology; 2009 Aug; 55(2):135-44. PubMed ID: 19694820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic Management of Patients With Prosthetic Heart Valves.
    Sanaani A; Yandrapalli S; Harburger JM
    Cardiol Rev; 2018; 26(4):177-186. PubMed ID: 29608496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Bioprosthetic Valve Thrombosis - Should Long-Term Anticoagulation Be Considered?
    Yong MS; Grant R; Saxena P; Yadav S
    Heart Lung Circ; 2018 Jun; 27(6):e70-e72. PubMed ID: 29277547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment alternatives in mechanical valve thrombosis].
    Duran NE; Biteker M; Ozkan M
    Turk Kardiyol Dern Ars; 2008 Sep; 36(6):420-5. PubMed ID: 19155650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy after mechanical mitral valve replacement.
    Vural KM; Ozatik MA; Uncu H; Emir M; Yurdagök O; Sener E; Tasdemir O
    J Heart Valve Dis; 2003 May; 12(3):370-6. PubMed ID: 12803338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine bioprosthetic heart valves: The next generation.
    Manji RA; Menkis AH; Ekser B; Cooper DK
    Am Heart J; 2012 Aug; 164(2):177-85. PubMed ID: 22877802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration.
    Marro M; Kossar AP; Xue Y; Frasca A; Levy RJ; Ferrari G
    J Am Heart Assoc; 2021 Feb; 10(3):e018921. PubMed ID: 33494616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of phenprocoumon for the treatment of obstructing thrombus in bioprostheses in the aortic valve position.
    Jander N; Kienzle RP; Kayser G; Neumann FJ; Gohlke-Baerwolf C; Minners J
    Am J Cardiol; 2012 Jan; 109(2):257-62. PubMed ID: 22000772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive surface coating for preventing mechanical heart valve thrombosis.
    Lancellotti P; Aqil A; Musumeci L; Jacques N; Ditkowski B; Debuisson M; Thiry M; Dupont J; Gougnard A; Sandersen C; Cheramy-Bien JP; Sakalihasan N; Nchimi A; Detrembleur C; Jérôme C; Oury C
    J Thromb Haemost; 2023 Sep; 21(9):2485-2498. PubMed ID: 37196847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcome of Mechanical Pulmonary Valve Replacement in 121 Patients with Congenital Heart Disease.
    Dehaki MG; Ghavidel AA; Omrani G; Javadikasgari H
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):367-72. PubMed ID: 25184609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends.
    Sun JC; Davidson MJ; Lamy A; Eikelboom JW
    Lancet; 2009 Aug; 374(9689):565-76. PubMed ID: 19683642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: case report and a review of options for anticoagulation.
    Mahesh B; Evans S; Bryan AJ
    J Heart Valve Dis; 2002 Sep; 11(5):745-50. PubMed ID: 12358414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.